DSD-T020

Congenital adrenal hyperplasia (CAH) · 46,XY · DSD-T020

DSD-T020 · Congenital adrenal hyperplasia (CAH) · 1989 · Automated translation

Karyotype 46,XY

Classic salt-wasting 21-hydroxylase deficiency (congenital adrenal hyperplasia) with insulin resistance and suboptimal metabolic control.

Case fields and evidence

Category

Congenital adrenal hyperplasia (CAH)

Karyotype

46,XY

Diagnosis

Classic salt-wasting 21-hydroxylase deficiency (congenital adrenal hyperplasia) with insulin resistance and suboptimal metabolic control.

Follow-up

After 3 months, weight decreased by 2 kg and amenorrhea resolved; 17-OHP decreased to 1539 ng/dl and testosterone to 163 ng/dl, while androstenedione was unchanged (390 ng/dl); the patient discontinued metformin on her own and insulin was not re-measured.

General phenotype

Female, short stature, truncal obesity, hirsutism, acanthosis nigricans, amenorrhea; electrolytes, blood glucose, and blood pressure normal.

Imaging

Bone age X-ray: 16 years at chronologic age 15.5 years; the remainder not reported in the source text.

Laboratory findings

17-OHP 3410 ng/dl (reference 20–500), total testosterone 326 ng/dl (15–70), androstenedione 390 ng/dl (50–220); fasting insulin 10 μIU/ml (glucose 63 mg/dl), HOMA-IR 1.6 (reference <2.9).

Management

Hydrocortisone 20 mg in the morning and 10 mg at bedtime, fludrocortisone 50 μg/day; metformin 500 mg twice daily after meals added.

Pathology

Not reported in the source text.

Evidence level

See source

Clinical history

See source

Family history

See source

Growth and development

See source

External genital examination

See source

Puberty / Tanner

See source

Cite this resource

DSD Research Library | Congenital adrenal hyperplasia (CAH) · 46,XY · DSD-T020 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-T020?version=v1.4.0